A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Cabotegravir Ultra Long-acting Plus Rilpivirine Ultra Long-acting or Cabotegravir Long-acting Plus Rilpivirine Long-acting in Adults and Adolescents With HIV Who Are Virologically Suppressed on ART
This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Contact
Study Contact
- Name: US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
Study Contact Backup
- Name: EU GSK Clinical Trials Call Center
- Phone Number: +44 (0) 20 89904466
- Email: GSKClinicalSupportHD@gsk.com
Study Locations
-
-
-
Buenos Aires, Argentina, C1181ACH
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Marisa Sanchez
-
Buenos Aires, Argentina, C1425AGC
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Sebastian Nunez
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Buenos Aires, Argentina, C1023AAB
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Veronica Lacal Ridilenir
-
Buenos Aires, Argentina, 1427
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Pedro Cahn
-
Ciudad Autonoma Buenos Aires, Argentina, C1405CKC
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Ezequiel Cordova
-
Ciudad Autonoma Buenos Aires, Argentina, C1425AWK
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Gustavo Lopardo
-
Córdoba, Argentina, X5000JJS
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Marcelo Martins
-
Rosario, Argentina, 2000
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Sergio Lupo
-
San Miguel de Tucumán, Argentina, T4000IHE
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Juan Gonzalo Tomas
-
-
-
-
New South Wales
-
Darlinghurst, New South Wales, Australia, 2010
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Mark O'Reilly
-
Sydney, New South Wales, Australia, 2010
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Mark Bloch
-
-
Queensland
-
Taringa, Queensland, Australia, 4068
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Fiona Bisshop
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
-
Western Australia
-
Perth, Western Australia, Australia, 6000
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Mina John
-
-
-
-
-
Curitiba, Brazil, 80060-900
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Monica Maria Gomes da Silva
-
Nova Iguaçu, Brazil, 26030-380
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Aline Ramalho
-
Rio de Janeiro, Brazil, 21045900
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Beatriz Gilda Grinsztejn
-
Salvador, Brazil, 40110-060
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Carlos Roberto Alves
-
São Paulo, Brazil, 04121-000
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Jose Valdez Madruga
-
São Paulo, Brazil, 04037-030
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- ricardo diaz
-
-
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2T1
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Malcolm Hedgcock
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Y 4E9
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Jonathan Angel
-
Toronto, Ontario, Canada, M5G 1K2
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Mona Loutfy
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3J1
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Alexandra de Pokomandy
-
Montreal, Quebec, Canada, H2L 4E9
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Elise Sasseville
-
Montreal, Quebec, Canada, H2L 4P9
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Jason Szabo
-
Québec, Quebec, Canada, G1R 2J6
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Marie-Louise Vachon
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada, S4P 0W5
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Alexander Wong
-
-
-
-
-
Aichi, Japan, 460-0001
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Yoshiyuki Yokomaku
-
Kanagawa, Japan, 221-0855
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Yukihiro Yoshimura
-
Osaka, Japan, 540-0006
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Dai Watanabe
-
Tokyo, Japan, 162-8655
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Hiroyuki Gatanaga
-
Tokyo, Japan, 108-8639
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Eisuke Adachi
-
Tokyo, Japan, 113-8677
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Ryoko Sekiya
-
-
-
-
-
Guadajalara, Mexico, 44280
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Luz Alicia Gonzalez-Hernandez
-
Mexico City, Mexico, 06760
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Edgar Perez-Barragan
-
Mexico City, Mexico, 14080
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Alvaro Lopez Iñiguez
-
Mérida, Mexico, 97070
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Orlando Paredes Ceballos
-
-
Nuevo León
-
San Pedro Garza García, Nuevo León, Mexico, 66260
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Reynaldo Lara-Medrano
-
-
-
-
-
San Juan, Puerto Rico, 00909
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Javier Morales-Ramirez
-
-
-
-
-
Alicante, Spain, 03010
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Sergio Reus Bañuls
-
Badalona, Spain, 08005
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Anna Bonjoch Badia
-
Barcelona, Spain, 08035
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Joaquin Burgos Cibrian
-
Barcelona, Spain, 08036
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Josep Mallolas Masferrer
-
Barcelona, Spain, 08026
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Paula Prieto
-
Barcelona, Spain, 8907
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Arkaitz Imaz Vacas
-
Burgos, Spain, 09006
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Luis Buzon
-
Cartagena Murcia, Spain, 30202
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Francisco Jesús Vera Méndez
-
Córdoba, Spain, 14004
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Ignacio Pérez Valero
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Elche Alicante, Spain, 03203
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- MAR MASIA
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Madrid, Spain, 28031
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Guillermo Cuevas Tascon
-
Madrid, Spain, 28046
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Maria Luisa Montes Ramirez
-
Madrid, Spain, 28034
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Sergio Serrano Villar
-
Madrid, Spain, 28040
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Vicente Estrada
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Madrid, Spain, 28041
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Rafael Rubio
-
Madrid, Spain, 28007
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Cristina Diez Romero
-
Sabadell Barcelona, Spain, 08208
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Marta Navarro Vilasaró
-
Seville, Spain, Sevilla
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Juan Macias
-
Valencia, Spain, 46014
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Miguel García Deltoro
-
Vigo Pontevedra, Spain, 36312
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Antonio Ocampo Hermidia
-
-
Madrid
-
Pozuelo de Alarcón, Madrid, Spain, 28224
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Alberto Díaz de Santiago
-
-
-
-
-
Liverpool, United Kingdom, L7 8YE
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Emily Clarke
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
London, United Kingdom, W2 1NY
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Caroline Foster
-
London, United Kingdom, WC1E 6JB
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Sarah Pett
-
London, United Kingdom, SE1 7EH
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Julie Fox
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
London, United Kingdom, SW10 9NH
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Ruth Byrne
-
London, United Kingdom, E1 1FR
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Chloe Orkin
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
-
West Midlands
-
Birmingham, West Midlands, United Kingdom, B9 5SS
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Steve Taylor
-
-
-
-
Arizona
-
Phoenix, Arizona, United States, 85015
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Douglas Cunningham
-
-
California
-
Bakersfield, California, United States, 93309
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Franco Felizarta
-
Los Angeles, California, United States, 90027
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- William Towner
-
Los Angeles, California, United States, 90036
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Peter Ruane
-
San Diego, California, United States, 92103
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Timothy Wilkin
-
West Hollywood, California, United States, 90046
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- William Hardy
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Onyema Ogbuagu
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20017
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Theo Hodge
-
-
Florida
-
DeLand, Florida, United States, 32720
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Godson Oguchi
-
Fort Lauderdale, Florida, United States, 33316
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Michael Sension
-
Ft. Pierce, Florida, United States, 34982-7148
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Moti Ramgopal
-
Jacksonville, Florida, United States, 32209
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Mobeen Rathore
-
Miami, Florida, United States, 33136
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Charles Mitchell
-
Orlando, Florida, United States, 32803-1851
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Charlotte-Paige Rolle
-
Pensacola, Florida, United States, 32503
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Mitchell Whitehead
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Vero Beach, Florida, United States, 32960-6541
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Gerald Pierone
-
West Palm Beach, Florida, United States, 33409
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Hector Bolivar
-
West Palm Beach, Florida, United States, 33407
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Olayemi Osiyemi
-
-
Georgia
-
Decatur, Georgia, United States, 30033
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Alexandra Dretler
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Mariam Aziz
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Allison Agwu
-
-
Michigan
-
Grosse Pointe Woods, Michigan, United States, 48236
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Leonard Johnson
-
-
Missouri
-
Kansas City, Missouri, United States, 64111
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Blair Thedinger
-
-
Nevada
-
Las Vegas, Nevada, United States, 89101
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Jerry Cade
-
-
New Jersey
-
Newark, New Jersey, United States, 07102-1909
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Jihad Slim
-
-
New Mexico
-
Santa Fe, New Mexico, United States, 87505-4753
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Joel Gallant
-
-
New York
-
Stony Brook, New York, United States, 11794
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Sharon Nachman
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Syracuse, New York, United States, 13057
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Elizabeth Asiago-Reddy
-
-
North Carolina
-
Greensboro, North Carolina, United States, 27401
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Cornelius Van Dam
-
Winston-Salem, North Carolina, United States, 27157
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Caryn Morse
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Jose Bazan
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- William Short
-
Pittsburgh, Pennsylvania, United States, 15212
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Chiu-Bin Hsiao
-
Pittsburgh, Pennsylvania, United States, 15213-3403
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Sharon Riddler
-
-
Tennessee
-
Memphis, Tennessee, United States, 38105-3678
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Aditya Gaur
-
-
Texas
-
Austin, Texas, United States, 78705-3326
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Cynthia Brinson
-
Dallas, Texas, United States, 75246-2004
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Christopher Bettacchi
-
Dallas, Texas, United States, 75219-4308
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Marc Tribble
-
El Paso, Texas, United States, 79902
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Ogechika Alozie
-
Houston, Texas, United States, 77098
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Gordon Crofoot, Jr., MD
-
-
Utah
-
Salt Lake City, Utah, United States, 84102
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Harry Rosado-Santos
-
-
Virginia
-
Lynchburg, Virginia, United States, 24501
- Recruiting
- GSK Investigational Site
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Joseph Saabiye
-
-
Washington
-
Seattle, Washington, United States, 98104
- Recruiting
- GSK Investigational Site
-
Principal Investigator:
- Peter Shalit
-
Contact:
- US GSK Clinical Trials Call Center
- Phone Number: 877-379-3718
- Email: GSKClinicalSupportHD@gsk.com
-
Contact:
- EU GSK Clinical Trials Call Centre
- Phone Number: +44 (0) 20 8990 4466
- Email: GSKClinicalSupportHD@gsk.com
-
Principal Investigator:
- Audrey Li
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
Patient Study Participant (PSP) Inclusion criteria
- Adults and adolescents with HIV-1 infection aged 12 years or older with a weight >35 kg.
- Documented HIV-1 RNA measurements <50 copies/mL in the 12 months prior to Screening.
- HIV-1 RNA <50 copies/mL at screening assessment.
- Must be on current daily oral antiretroviral regimen for at least 6 months uninterrupted prior to Screening.
- Any prior switch in therapy must have occurred due to tolerability/safety, access to medications, or convenience/simplification, and must NOT have been done for virologic treatment failure (HIV-1 RNA ≥200 copies/mL).
Exclusion criteria:
Patient Study Participant (PSP) Exclusion criteria
- Any evidence of primary resistance based on the presence of any major known INSTI (including CAB) or NNRTI (including RPV) resistance-associated mutation
- Treatment with an HIV-1 immunotherapeutic vaccine within 90 days of screening
- Any history of receiving long-acting therapy for treatment or prevention of HIV
- Previous exposure to injectable CAB and/or injectable RPV for treatment or prevention of HIV-1 infection
- Significant uncontrolled or clinically relevant comorbidities (e.g., cardiovascular, hepatic, renal, neurological, psychiatric) that may impact safety or study participation
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: CAB ULA+ RPV ULA
Participants will receive CAB ULA+RPV ULA. |
CAB ULA will be administered. RPV ULA will be administered. |
|
Active Comparator: CAB LA+ RPV LA
Participants will receive CAB LA+RPV LA. |
CAB LA will be administered. RPV LA will be administered. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percentage of participants with plasma HIV-RNA greater than or equal to (>=) 50 copies (c)/mL as per Food and Drug Administration (FDA) Snapshot algorithm
Time Frame: At Month 11
|
At Month 11
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of participants with plasma HIV-RNA >= 50 c/mL as per FDA Snapshot algorithm
Time Frame: At Month 23
|
At Month 23
|
|
|
Percentage of participants with plasma HIV-RNA less than (<) 50 c/mL as per FDA Snapshot algorithm
Time Frame: At Month 11 and Month 23
|
At Month 11 and Month 23
|
|
|
Number of participants with treatment emergent genotypic or phenotypic resistance to CAB and RPV
Time Frame: Up to Month 23
|
Up to Month 23
|
|
|
Percentage of participants with confirmed virologic failure (CVF)
Time Frame: Up to Month 11 and Month 23
|
CVF is defined as 2 consecutive HIV-1 RNA levels >=200 c/mL. |
Up to Month 11 and Month 23
|
|
Number of participants with drug-related adverse events (AEs) as per severity of Grade 2-5
Time Frame: Up to Month 11 and Month 23
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of a study intervention, whether or not considered related to the study intervention. Severity is graded according to the Division of Acquired Immunodeficiency Syndrome (DAIDS) grading criteria, where Grade 2 = moderate, Grade 3 = severe, Grade 4 = potentially life-threatening, Grade 5 = death. |
Up to Month 11 and Month 23
|
|
Number of participants with drug-related serious adverse events (SAEs)
Time Frame: Up to Month 11 and Month 23
|
An SAE is defined as any untoward medical occurrence that results in death, is life threatening, requires hospitalization or prolongs existing hospitalization, results in disability/incapacity or other medically significant events. |
Up to Month 11 and Month 23
|
|
Number of participants who discontinue treatment due to AEs or injection intolerability
Time Frame: Up to Month 11 and Month 23
|
Up to Month 11 and Month 23
|
|
|
Plasma concentrations of CAB and RPV
Time Frame: Up to Month 23
|
Up to Month 23
|
|
|
Percentage of adolescent participants with plasma HIV-RNA >= 50 c/mL as per FDA Snapshot algorithm
Time Frame: At Month 11 and Month 23
|
At Month 11 and Month 23
|
|
|
Percentage of adolescent participants with plasma HIV-RNA < 50 c/mL as per FDA Snapshot algorithm
Time Frame: At Month 11 and Month 23
|
At Month 11 and Month 23
|
|
|
Percentage of adolescent participants with confirmed virologic failure (CVF)
Time Frame: Up to Month 11 and Month 23
|
CVF is defined as 2 consecutive HIV-1 RNA levels >=200 c/mL. |
Up to Month 11 and Month 23
|
|
Absolute value of Cluster of Differentiation 4 (CD4+) cell counts in adolescent participants
Time Frame: Up to Month 11 and Month 23
|
Up to Month 11 and Month 23
|
|
|
Change from Baseline in CD4+ cell counts in adolescent participants
Time Frame: At Month 11 and Month 23 compared to baseline (Day 1)
|
At Month 11 and Month 23 compared to baseline (Day 1)
|
|
|
Number of adolescent participants with drug-related AEs as per severity of Grade 2-5
Time Frame: Up to Month 11 and Month 23
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of a study intervention, whether or not considered related to the study intervention. Severity is graded according to the Division of Acquired Immunodeficiency Syndrome (DAIDS) grading criteria, where Grade 2 = moderate, Grade 3 = severe, Grade 4 = potentially life-threatening, Grade 5 = death. |
Up to Month 11 and Month 23
|
|
Number of adolescent participants with drug-related SAEs
Time Frame: Up to Month 11 and Month 23
|
An SAE is defined as any untoward medical occurrence that results in death, is life threatening, requires hospitalization or prolongs existing hospitalization, results in disability/incapacity or other medically significant events. |
Up to Month 11 and Month 23
|
|
Number of adolescent participants who discontinue treatment due to AEs or injection intolerability
Time Frame: Up to Month 11 and Month 23
|
Up to Month 11 and Month 23
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 222794
- 2024-518511-19-00 (Registry Identifier: CTIS (EU))
- NCT07650916 (Registry Identifier: ClinicalTrials.gov)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Study Sponsor will assess requests from qualified researchers for anonymized individual patient-level data and related study documents. Data sharing is subject to certain criteria, conditions, and exceptions. For further information, refer to https://www.viiv-studyregister.com/documents/About_ViiV_Patient_Level_Data_Sharing_Final_28May2026.pdf
IPD Sharing Time Frame
Anonymized IPD will be made available within 6 months of publication of primary, key secondary and safety results for studies in product with approved indication(s) or asset(s) with development terminated across all indications.
IPD Sharing Access Criteria
Anonymized IPD is shared with researchers whose proposals are approved by an Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months, but an extension may be granted, when justified, for up to 6 months.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.